Skip to content
PeptideAI
Human RCTgut healthimmuneinflammation

Colostrum-derived peptides

Oral immunoglobulin and growth-factor fractions from bovine colostrum, taken in gram quantities to bind gut antigens and support mucosal barrier repair — the most accessible and best-tolerated thing in this category.

Also known as bovine colostrum, colostrum peptide fraction, serum-derived bovine immunoglobulin, SBI, IgG concentrate, EnteraGam, ImmunoLin, Colostrum-LD

Human RCT — Randomised controlled trials in humans, but not an approved product for this use.

This is the best-evidenced non-prescription entry in the category. Small randomised human trials show bovine colostrum reduces NSAID-induced and exercise-induced increases in intestinal permeability, and reduces infectious diarrhoea incidence. Serum-derived bovine immunoglobulin has randomised data in IBS-D and HIV enteropathy. The effect sizes are modest and the trials are small, but they are real human trials.

How it works

Bovine colostrum is not a single peptide but a mixture whose active fractions include IgG (which binds bacterial antigens and toxins in the lumen without being absorbed), lactoferrin (iron sequestration plus direct antimicrobial and immunomodulatory action), proline-rich polypeptides (immune signalling), and growth factors including IGF-1, TGF-beta and EGF that support epithelial proliferation. In human studies, bovine colostrum reduces the increase in intestinal permeability caused by NSAIDs and by heavy exercise heat stress, both measured by lactulose/mannitol ratio. Serum-derived bovine immunoglobulin, a related prescription medical food, is not actually colostrum-derived but works by the same luminal antigen-binding principle and has trial data in IBS-D and HIV enteropathy. The growth factors are largely digested; the immunoglobulin and antigen-binding activity is what most reliably survives to act locally.

Targets: Luminal bacterial antigens and toxins, Tight junction integrity, Intestinal epithelial proliferation, Mucosal IgA and innate immune signalling

Dosing

ProtocolDoseFrequencyRoute
Bovine colostrum powder, gut barrier supportAway from hot liquids, which denature immunoglobulins. Often first thing in the morning and before bed on an empty stomach.—once or twice dailyoral
Serum-derived bovine immunoglobulin (EnteraGam)Mixed into water or food; not with hot liquid.—once or twice dailyoral
  • · Dosed in grams, not micrograms: 10 to 20 g of colostrum powder daily is the range used in the permeability trials, split into two doses. Low-heat or 'liposomal delivery' processed products retain more IgG. Standardised IgG content matters far more than brand.
  • · Dosed at 5 to 10 g per day as a prescription medical food. Higher doses of 10 g twice daily have been used in HIV enteropathy studies.

Titration

Start at half dose for the first week if you are prone to bloating; the lactose content in cheaper colostrum products is the usual culprit for early GI upset.

Cycling

Generally taken continuously — it is a food-derived protein with an excellent safety record. Most people run 8-12 weeks and then decide based on symptoms whether to continue.

Work out your exact syringe units →

Pharmacology

Half-life
Not applicable in a systemic sense — the active fractions are intended to act in the lumen and are cleared with gut transit rather than absorbed.
Onset
Permeability measures improve within days in exercise and NSAID challenge studies; symptomatic gut benefit is usually reported over 2-8 weeks.
Routes
oral
Molecule
Complex biological fraction — immunoglobulins, lactoferrin, proline-rich polypeptides, IGF-1 and TGF-beta

Handling

Diluent
Not applicable — oral powder mixed into cool or room-temperature liquid.
Lyophilised
Powder in a sealed container, cool and dry; refrigeration extends shelf life once opened.
Reconstituted
Once mixed with liquid, consume immediately.

Mixing

Never mix into hot liquid. Heat denatures the immunoglobulins that constitute most of the actual activity.

Side effects

  • commonBloating and gas in the first week— Frequently lactose-related; a low-lactose or IgG-concentrated product usually fixes it.
  • uncommonNausea
  • uncommonLoose stools
  • rareAllergic reaction in dairy or beef protein allergy— This is bovine protein. Genuine milk protein allergy is a hard stop, distinct from lactose intolerance.

Do not use if

  • IgE-mediated cow's milk protein allergy — risk of a genuine allergic reaction.
  • Beef protein allergy for serum-derived bovine immunoglobulin products.
  • Galactosaemia.

Combining it

  • synergybpc-157-gut — Commonly stacked in gut protocols; different mechanisms, no known conflict.
  • conflicthot-beverages — Not a drug interaction but the single most common way people waste their money — heat destroys the immunoglobulin fraction.
  • cautionigf-1-lr3 — Colostrum contains bovine IGF-1, though oral IGF-1 is largely digested and does not meaningfully raise serum levels at normal doses.

What to monitor

  • · Symptom tracking is the practical endpoint; faecal calprotectin if there is underlying inflammatory disease.
  • · Lactulose/mannitol permeability testing if you want an objective barrier measure.

Legal status

Bovine colostrum is sold as a dietary supplement in the US and EU. EnteraGam is a prescription medical food in the US, not a drug.

References

  • Playford et al., bovine colostrum reduces NSAID-induced gut permeability increase, Gut / Clinical Science (trial)
  • Wilson et al., serum-derived bovine immunoglobulin in IBS-D (trial)
  • Rathe et al., bovine colostrum against gastrointestinal disease, systematic review (review)

Mechanism in depth

Colostrum is the one thing in this class where the mechanism is less interesting than the evidence, and that is a compliment. The primary active principle is luminal immunoglobulin. Bovine IgG binds bacterial antigens, lipopolysaccharide and toxins in the gut lumen without being absorbed. That reduces the antigenic load presented to the epithelium and to gut-associated lymphoid tissue. It is passive immunity applied topically to a mucosal surface — the same thing colostrum does for a calf, repurposed for an adult intestine. This is also exactly how serum-derived bovine immunoglobulin works, and why SBI is not actually colostrum but behaves similarly. Lactoferrin adds two things: iron sequestration, which deprives siderophilic bacteria, and direct membrane-disrupting antimicrobial activity, plus immunomodulatory signalling through several receptors. The growth factor fraction is where marketing outruns pharmacology. Colostrum genuinely contains IGF-1, TGF-beta and EGF, and these genuinely promote epithelial proliferation in vitro. In an adult gut most of them are digested. The honest position is that they may act locally on the proximal epithelium before degradation, but they are not delivering a systemic growth factor dose, and anyone selling colostrum on the basis of its IGF-1 content is selling something that does not reach the bloodstream. What elevates colostrum above everything else non-prescription in this category is that the mechanism has been tested in humans on a hard endpoint. Playford and colleagues showed that co-administering bovine colostrum blunted the acute rise in intestinal permeability caused by indomethacin, measured by lactulose/mannitol ratio. Marchbank and colleagues showed the same protective effect against the permeability increase caused by heavy exercise in athletes. These are small randomised human trials with an objective, quantitative barrier measurement — not symptom questionnaires, and not rodents. That matters for calibration. BPC-157 has rodent data and confident forum posts. Larazotide had a mechanism and a failed phase 3. Colostrum has small positive human trials on the exact endpoint the whole 'leaky gut' category claims to address. It is not a large effect and the trials are not big. But it is real human data and it is the best in this category.

What usually goes wrong

Heat. It is the number one failure and it is trivially avoidable. Immunoglobulins are the main active fraction and they are heat-labile. Hot liquid destroys them, and a large proportion of people taking colostrum are taking a denatured protein powder with no advantage over any other protein powder. The second is product selection. Colostrum is a supplement, so the specification varies enormously. Standardised IgG content is the number that matters and many products do not state it. Low-temperature or flash-processed products retain more activity. Brand marketing correlates poorly with IgG content. The third is confusing lactose intolerance with milk protein allergy. Early bloating on colostrum is usually lactose from a cheaper, less purified product, and switching to a low-lactose or IgG-concentrated product usually fixes it. IgE-mediated cow's milk protein allergy is a completely different thing and is a hard stop with genuine anaphylaxis risk. The fourth is buying it for the IGF-1. Oral IGF-1 is digested and does not meaningfully raise serum levels. If you want systemic growth factor effects, this is not how you get them — and if you are worried about them, you do not need to be at food doses. The fifth is underdosing. The human permeability trials used 10-20 g per day. A 500 mg capsule twice a day is roughly one fortieth of a trial dose. A great deal of colostrum is sold in capsule formats that cannot plausibly deliver the dose that produced the evidence. The sixth is using it as a substitute for investigating a real problem. It is well tolerated enough that people take it for years instead of finding out why their gut is not working.

Titration ladder

  1. 5000 mgWeek 1 — 5 g daily (half the usual dose) to establish tolerance. Early bloating and gas are usually lactose-related rather than a reaction to the immunoglobulin fraction, and starting low identifies that without abandoning the product. Note the dose is in grams — this entry shows 5 g expressed in micrograms because the schema requires that unit.
  2. 10000 mgWeeks 2-12 — 10 g daily, split into two doses, in cool or room-temperature liquid. This is the low end of the range used in the human permeability trials.
  3. 20000 mgWeeks 2-12, higher end — Up to 20 g daily split into two doses. The permeability trials used doses in the 10-20 g range. Serum-derived bovine immunoglobulin is dosed lower, at 5-10 g daily, with 10 g twice daily used in HIV enteropathy studies.
  4. —Week 12 — Reassess. This is a food-derived protein with an excellent safety record, so continuing indefinitely is defensible if it is helping — but decide on evidence rather than momentum, ideally with a repeat permeability measure.

Bloodwork worth running

MarkerWhenWhy it matters
Lactulose/mannitol urinary ratioBaseline and after 4-8 weeks.This is the endpoint on which colostrum has actual human evidence, so it is the endpoint worth measuring. It quantifies paracellular permeability directly rather than asking how your stomach feels.Act if: An unchanged ratio after eight weeks in someone whose baseline was elevated means it is not working for you. Stop.
Faecal calprotectinBaseline and at 8-12 weeks if there is diagnosed inflammatory disease.If there is underlying inflammatory bowel disease, this is the objective marker. Colostrum is an adjunct in that setting, not a treatment, and calprotectin is what tells you whether you are drifting.Act if: Rising calprotectin means the underlying disease needs attention regardless of how the colostrum is going.
Serum IGF-1Baseline and at 8 weeks if the question matters to you.Worth measuring once, mostly to settle the question. Colostrum contains bovine IGF-1 and this generates recurring anxiety about systemic effects. Oral IGF-1 is largely digested and does not meaningfully raise serum levels at normal doses. Measuring it once at baseline and once after eight weeks resolves the concern with data rather than argument.Act if: A genuine rise would be unexpected and would warrant stopping. In practice it does not happen at food doses.
Ferritin and full blood countBaseline and at 12 weeks if you are iron-deficient or a menstruating adult.Lactoferrin binds iron avidly. Whether high-dose colostrum meaningfully affects iron status in an adult has not been studied, and anyone already iron-deficient should know their numbers before taking grams of an iron-binding protein daily.Act if: Falling ferritin means separate colostrum from iron supplementation by several hours and recheck.
Cow's milk protein allergy statusBefore starting.Not a monitoring test but a hard gate. This is bovine protein, and IgE-mediated cow's milk protein allergy is a genuine anaphylaxis risk — entirely distinct from lactose intolerance, which merely causes bloating.Act if: Known IgE-mediated milk or beef protein allergy is a hard stop, not a caution.

Pharmacokinetics

Crosses blood-brain barrier
no
Metabolism
Ordinary gastric and pancreatic proteolysis. Notably, colostrum contains protease inhibitors that partially protect its own immunoglobulins from digestion — this is not an accident of processing, it is how colostrum works in a neonate.
Elimination
Faecal, as digested protein.

Receptor targets

  • Luminal bacterial antigens, lipopolysaccharide and toxins — Polyclonal antibody binding across a broad antigen range; no single affinity applies.

    Immunoglobulin G binds and sequesters antigens in the lumen without being absorbed, reducing the antigenic load reaching the epithelium and gut-associated lymphoid tissue. This is the principal and most reliably surviving mechanism.

  • Iron (lactoferrin) — Very high affinity iron binding.

    Sequesters iron from siderophilic bacteria, plus direct cationic membrane disruption and receptor-mediated immunomodulation.

  • Tight junction proteins and epithelial barrier — Indirect.

    Reduced permeability, demonstrated in humans by blunted lactulose/mannitol ratio increases after NSAID challenge and after exercise heat stress. Whether this is a direct tight-junction effect or a consequence of reduced antigenic and inflammatory stress is not resolved.

  • Intestinal epithelial growth factor receptors (IGF-1R, EGFR, TGF-beta receptors) — Native ligands present, but largely digested before reaching most of the gut.

    Possible local proximal epithelial proliferative effect. Do not expect systemic growth factor activity — oral IGF-1 does not meaningfully raise serum IGF-1 at these doses.

Trials

  • Co-administration of the health food supplement bovine colostrum reduces the acute NSAID-induced increase in intestinal permeability (Playford et al.) Randomised human trial · 2001

    Change in intestinal permeability measured by lactulose/mannitol ratio after indomethacin challenge, with and without bovine colostrum. Colostrum blunted the permeability increase. Clinical Science (London) 2001;100(6):627-33.

  • The nutriceutical bovine colostrum truncates the increase in gut permeability caused by heavy exercise in athletes (Marchbank et al.) Randomised human trial · 2011

    Change in intestinal permeability after heavy exercise, with and without bovine colostrum supplementation. Colostrum truncated the exercise-induced permeability rise.

What to expect, and when

Permeability measures improve within days in the acute NSAID and exercise challenge studies — in the Playford work, colostrum was co-administered and the protection was immediate. Symptomatic gut benefit in chronic use is typically reported over 2-8 weeks. Early bloating, if it occurs, appears in the first week and usually settles or resolves with a lower-lactose product. Judge it at eight weeks, ideally with a permeability measure at each end.

Stacking and comparisons

Colostrum is the safest thing in this category and the easiest to combine, which is precisely why it should be the first thing you run alone. If you start colostrum, BPC-157 and KPV in the same week and improve, you have learned nothing about which one did it. Run colostrum for four weeks by itself first — it has the best safety profile and the best evidence, so it is the rational base layer. The single most common way people waste money on this is heat. Immunoglobulins denature. Mixing colostrum powder into hot coffee, hot tea or hot porridge destroys the fraction that carries most of the activity. Cool or room-temperature liquid only, always. Separate it from iron supplements by several hours. Lactoferrin binds iron avidly and there is no reason to have them in the stomach together. It combines sensibly with BPC-157 and KPV — different mechanisms, no known conflict — and with a soluble fibre. If you are running a luminal antimicrobial of any kind, including rifaximin, the theoretical pairing with colostrum is attractive and entirely untested. The practical note on cost: at 10-20 g daily this is the most consumed product in the category by mass, so the price per gram matters more than it does for anything else here.

Colostrum is the best-evidenced non-prescription entry in this entire category, and it is worth being precise about what that means. It has small randomised human trials with objective permeability endpoints in two independent stressor models. That is a lower tier of evidence than linaclotide's thousands of randomised patients and a much higher tier than BPC-157's rodent studies. Against larazotide, the comparison is instructive. Larazotide had a more elegant, more specific mechanism, far more money behind it, and a proper phase 3 — which failed. Colostrum has a crude, mixture-based mechanism, no pharmaceutical development, and small positive human trials on the same endpoint. In this category, evidence has not tracked elegance. Against BPC-157 and KPV, colostrum is the one you can actually justify. It is a food-derived protein with an excellent safety record, human data on the endpoint in question, and a cost that scales with grams rather than micrograms. Its weaknesses are real: the effect sizes are modest, the trials are small, the product is unstandardised, and it does nothing for inflammation the way KPV plausibly does or for mucosal repair the way BPC-157 claims to. It is a barrier-support agent, not a treatment for inflammatory bowel disease. Serum-derived bovine immunoglobulin is the more standardised, prescription-grade version of the same principle, with randomised data in IBS-D and HIV enteropathy. If you want the mechanism with quality control, that is the route.

Rough cost

$30–$120/month. Bovine colostrum powder at 10-20 g daily, which is 300-600 g per month. Low-temperature processed and IgG-standardised products sit at the top of that range and are worth the difference; commodity spray-dried powder is cheap and may have lost much of its activity. Serum-derived bovine immunoglobulin (EnteraGam) is a prescription medical food and costs substantially more — I did not verify its price. These are observed market ranges, not verified figures.

Genuinely uncertain

  • Participant numbers for the Playford 2001 and Marchbank 2011 trials were not resolved in this session and are left null. Both are small studies.
  • The Wilson et al. SBI in IBS-D trial referenced in the Core record was not resolved to a specific PMID; the Good 2015 review and Petschow 2014 mechanism paper are cited instead.
  • The Rathe et al. systematic review referenced in the Core record was not resolved to a PMID in this session.
  • Whether high-dose lactoferrin-containing colostrum meaningfully affects iron status in adults has not been studied as far as I could determine; the monitoring suggestion is precautionary reasoning, not evidence.
  • The claim that low-temperature processing preserves more IgG is mechanistically obvious and widely stated by manufacturers, but I did not resolve an independent comparative analysis of commercial products.
  • The dose-response relationship for colostrum is essentially uncharacterised. The 10-20 g range comes from what the trials used, not from any dose-ranging study.
  • The Playford 2001 record in PubMed did not list a DOI, so that field is empty.

Papers